Bank of America
AUTL

Bank of America’s Autolus Therapeutics AUTL Stock Holding History

Bank of America’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Sell
1,605,092
-239,579
-13% -$376K ﹤0.01% 4035
2026
Q1 		$2.55M Sell
1,844,671
-116,095
-6% -$176K ﹤0.01% 3950
2025
Q4 		$3.9M Sell
1,960,766
-68,827
-3% -$106K ﹤0.01% 3578
2025
Q3 		$3.31M Buy
2,029,593
+1,054,458
+108% +$2.06M ﹤0.01% 4385
2025
Q2 		$2.22M Buy
975,135
+942,540
+2,892% +$1.56M ﹤0.01% 4678
2025
Q1 		$50.5K Sell
32,595
-14,003
-30% -$28.4K ﹤0.01% 6742
2024
Q4 		$110K Sell
46,598
-220,442
-83% -$745K ﹤0.01% 6352
2024
Q3 		$969K Buy
267,040
+13,547
+5% +$54K ﹤0.01% 5078
2024
Q2 		$882K Sell
253,493
-8,033
-3% -$34.7K ﹤0.01% 4977
2024
Q1 		$1.67M Buy
261,526
+220,235
+533% +$1.37M ﹤0.01% 4567
2023
Q4 		$266K Buy
41,291
+40,669
+6,538% +$155K ﹤0.01% 5914
2023
Q3 		$1.45K Sell
622
-4,213
-87% -$12K ﹤0.01% 7186
2023
Q2 		$11.5K Buy
4,835
+4,182
+640% +$9.92K ﹤0.01% 6825
2023
Q1 		$1.2K Buy
653
+136
+26% +$266 ﹤0.01% 7279
2022
Q4 		$982 Hold
517
– – ﹤0.01% 7348
2022
Q3 		$1K Sell
517
-109
-17% -$323 ﹤0.01% 7646
2022
Q2 		$2K Sell
626
-2,078
-77% -$6.32K ﹤0.01% 7761
2022
Q1 		$11K Sell
2,704
-14,992
-85% -$63K ﹤0.01% 7699
2021
Q4 		$92K Buy
17,696
+3,505
+25% +$21K ﹤0.01% 6919
2021
Q3 		$93K Buy
14,191
+13,979
+6,594% +$88.3K ﹤0.01% 6761
2021
Q2 		$1K Sell
212
-26,385
-99% -$164K ﹤0.01% 7589
2021
Q1 		$152K Buy
26,597
+26,033
+4,616% +$193K ﹤0.01% 6208
2020
Q4 		$5K Sell
564
-28,374
-98% -$302K ﹤0.01% 6815
2020
Q3 		$337K Buy
28,938
+28,883
+52,515% +$419K ﹤0.01% 4985
2020
Q2 		$1K Sell
55
-415
-88% -$4.6K ﹤0.01% 6716
2020
Q1 		$3K Sell
470
-202
-30% -$1.87K ﹤0.01% 6562
2019
Q4 		$9K Buy
672
+552
+460% +$7.23K ﹤0.01% 6660
2019
Q3 		$1K Sell
120
-1,389
-92% -$18.4K ﹤0.01% 7076
2019
Q2 		$24K Buy
1,509
+1,462
+3,111% +$32.7K ﹤0.01% 6522
2019
Q1 		$1K Sell
47
-901
-95% -$25.6K ﹤0.01% 6960
2018
Q4 		$31K Buy
+948
New +$31.2K ﹤0.01% 6365

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America's AUTL Position: Q2 2026 in Review

Bank of America reduced its Autolus Therapeutics (AUTL) stake by 13% in Q2 2026, selling an estimated $376K and leaving 1,605,092 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #4035.

Bank of America first reported a position in AUTL in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.9M in Q4 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Bank of America held 1,605,092 shares of Autolus Therapeutics worth $2.57M as of Q2 2026.
  • Bank of America sold 239,579 Autolus Therapeutics shares in Q2 2026, an estimated $376K.
  • Autolus Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4035 holding.
  • Bank of America first reported a position in Autolus Therapeutics in Q4 2018 and has held it in 31 quarters since.
  • Bank of America's Autolus Therapeutics position peaked at $3.9M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.